BIOS Capital Management, LP Long-Term Concentrated

CIK: 0001813845 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 13, 2026

Total Value ($000): $82,623 (100.0% shares, 0.0% debt)

Holdings (6)

New Positions (1)

INAB IN8BIO INC 0.7%

Value ($000) $593 Shares 253,417 Est. Cost $1.90 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INAB	IN8BIO INC	253,417	$593	0.7%	$1.90	0.0%	COM NEW	45674E208

Exited Positions (1)

— IN8BIO INC 0.8%

Value ($000) $622 Shares 286,664 Est. Cost $0.26 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	IN8BIO INC	286,664	$622	0.8%	$0.26	—	—	45674E109

Unchanged Positions (5)

ACTU ACTUATE THERAPEUTICS INC 74.4%

Value ($000) $61,506 Shares 10,049,996 Est. Cost $8.16 Unrealized -15.8%

LTRN LANTERN PHARMA INC 3.7%

Value ($000) $3,059 Shares 1,009,507 Est. Cost $3.42 Unrealized +8.7%

IRD OPUS GENETICS INC 9.0%

Value ($000) $7,404 Shares 3,683,429 Est. Cost $0.99 Unrealized +105.9%

RNTX REIN THERAPEUTICS INC 2.4%

Value ($000) $1,961 Shares 1,690,751 Est. Cost $3.03 Unrealized -54.5%

CGTX COGNITION THERAPEUTICS INC 9.8%

Value ($000) $8,100 Shares 6,000,000 Est. Cost $0.49 Unrealized +228.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACTU	ACTUATE THERAPEUTICS INC	10,049,996	$61,506	74.4%	$8.16	-15.8%	COM	005083100
LTRN	LANTERN PHARMA INC	1,009,507	$3,059	3.7%	$3.42	+8.7%	COM	51654W101
IRD	OPUS GENETICS INC	3,683,429	$7,404	9.0%	$0.99	+105.9%	COM	67577R102
RNTX	REIN THERAPEUTICS INC	1,690,751	$1,961	2.4%	$3.03	-54.5%	COM NEW	00887A204
CGTX	COGNITION THERAPEUTICS INC	6,000,000	$8,100	9.8%	$0.49	+228.3%	COM	19243B102